{"product_id":"kobayashi-bcg-matrix","title":"Kobayashi Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSee the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe Kobayashi BCG Matrix offers a concise snapshot of product performance across market growth and relative share, highlighting potential Stars, Cash Cows, Question Marks, and Dogs to prioritize resource allocation and strategic focus.\u003c\/p\u003e\n\u003cp\u003eThis preview outlines key dynamics but the full BCG Matrix delivers quadrant-level placements, data-driven recommendations, and a tactical roadmap to optimize portfolio value—purchase now for the complete Word report and editable Excel summary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eU.S. Body Warmers Division\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe U.S. Body Warmers Division is a Star: Kobayashi holds a leading North American market share in disposable body warmers as demand for heat therapy rises in colder states, and the company doubled Georgia factory capacity by end-2025 to meet that growth.\u003c\/p\u003e\n\u003cp\u003eRevenue is strong—estimated mid-2025 annual sales around 30–40 billion yen—but the division consumed cash after an 8 billion yen capital spend for expansion, raising short-term free cash outflows while defending its rapid-growth position.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoutheast Asian Consumer Healthcare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKobayashi targets Southeast Asian consumer healthcare as a Star, focusing on Malaysia and Thailand where hygiene and cooling product sales grew ~12–18% CAGR 2020–2024; market size in 2024 ~USD 2.1bn in Malaysia+Thailand combined. \u003c\/p\u003e\n\u003cp\u003eThe firm will open a local plant by end-2025 to cut costs ~8–12% and speed time-to-market, aiming to convert high awareness and rising GDP per capita (Malaysia USD 11,000; Thailand USD 8,400 in 2024) into dominant share. \u003c\/p\u003e\n\u003cp\u003eThis requires heavy capex (~USD 25–40m) and marketing spend (2–3% of forecasted regional revenues) to defend growth and scale distribution. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCooling Gel Sheets (Netsusama Sheet) International\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNetsusama Sheets are a BCG Matrix Star: global sales grew ~18% YoY to ¥12.4bn in FY2024, driven by 25% volume growth in Southeast Asia and Africa where they replace antipyretic meds for pediatric fever care.\u003c\/p\u003e\n\u003cp\u003eDomestic growth is steady at ~4% CAGR since 2021, while international (ex-China) revenue rose 32% in 2024, showing strong brand equity and high market share in 12 countries.\u003c\/p\u003e\n\u003cp\u003eTo stay first-to-market against local entrants, continue promotional spend ~6–8% of product revenue and fund targeted R\u0026amp;D for formulation\/packaging localized by Q3 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital and E-commerce Health Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe shift to digital sales has made Kobayashi’s e-commerce a Star: online revenue grew ~18% CAGR 2020–2025, reaching about JPY 24.5 billion in 2025, attracting younger shoppers and avoiding retail shelves.\u003c\/p\u003e\n\u003cp\u003eIt demands heavy digital marketing and logistics spend—marketing up ~12% of online sales and fulfillment costs increasing 30% vs. 2019—yet secures recurring cash flow as online health shopping becomes permanent.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOnline revenue ~JPY 24.5bn (2025)\u003c\/li\u003e\n\u003cli\u003e18% CAGR 2020–2025\u003c\/li\u003e\n\u003cli\u003eMarketing ≈12% of online sales\u003c\/li\u003e\n\u003cli\u003eFulfillment costs +30% vs. 2019\u003c\/li\u003e\n\u003cli\u003eDrives younger demographics, reduces retail bottlenecks\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnovative Eyeglass and Screen Cleaners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eKobayashi’s niche cleaners, led by Megane Fukifuki, hold ~35% share in Japan’s specialized personal-care lens and screen-cleaning segment, a market growing ~6% CAGR 2022–25 as global device use rises to 6.6 billion smartphones in 2025.\u003c\/p\u003e\n\u003cp\u003eRising screen ownership and hygiene concerns push demand for convenient, lint-free wipes and sprays, making these products regional Stars in the BCG matrix.\u003c\/p\u003e\n\u003cp\u003eSustained investment in global distribution and retail placement—estimated $12–18M over 3 years—will be needed to keep growth above market average and avoid decline.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e35% domestic share\u003c\/li\u003e\n\u003cli\u003e6% segment CAGR (2022–25)\u003c\/li\u003e\n\u003cli\u003e6.6B smartphones in 2025\u003c\/li\u003e\n\u003cli\u003e$12–18M required distribution spend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiversified growth: US warmers, SEA health, e‑commerce and flagship product leadership\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: US Body Warmers (¥30–40bn sales 2025; ¥8bn capex 2024–25), SEA Consumer Health (plant capex USD25–40m; 12–18% CAGR 2020–24), Netsusama Sheets (¥12.4bn FY2024; 18% YoY), E‑commerce (¥24.5bn 2025; 18% CAGR), Megane Fukifuki (35% share; 6% CAGR).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eDivision\u003c\/th\u003e\n\u003cth\u003e2025 metric\u003c\/th\u003e\n\u003cth\u003eKey spend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS Body Warmers\u003c\/td\u003e\n\u003ctd\u003e¥30–40bn sales\u003c\/td\u003e\n\u003ctd\u003e¥8bn capex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSEA Health\u003c\/td\u003e\n\u003ctd\u003e12–18% CAGR\u003c\/td\u003e\n\u003ctd\u003eUSD25–40m capex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNetsusama\u003c\/td\u003e\n\u003ctd\u003e¥12.4bn FY2024\u003c\/td\u003e\n\u003ctd\u003e6–8% promo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE‑commerce\u003c\/td\u003e\n\u003ctd\u003e¥24.5bn 2025\u003c\/td\u003e\n\u003ctd\u003e12% marketing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMegane\u003c\/td\u003e\n\u003ctd\u003e35% share\u003c\/td\u003e\n\u003ctd\u003eUSD12–18m distro\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eConcise Kobayashi BCG Matrix overview: quadrant-by-quadrant strategic guidance—invest, hold, or divest—with competitive and trend context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Kobayashi BCG Matrix mapping units by growth and share for instant portfolio clarity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDomestic OTC Pharmaceuticals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKobayashi holds an 18.3% share of Japan’s OTC market, generating steady cash in a low-growth domestic market (market size ¥1.2 trillion in 2025). \u003c\/p\u003e\n\u003cp\u003eProducts—pain relief to digestive aids—need minimal promo spend due to strong brand loyalty and fixed shelf presence, keeping margins high (EBIT margin ~24% for segment in FY2024). \u003c\/p\u003e\n\u003cp\u003eSegment cash funds international expansion and R\u0026amp;D, contributing ~¥45 billion free cash flow over 2023–2025. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOral Hygiene and Dental Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKobayashi’s oral hygiene line — interdental brushes, specialized cleaners — holds roughly 35–40% share of Japan’s mature oral-care market (2024 sales ~¥28.5bn). Market growth is ~1–2% annually, so management focuses on cost efficiency and margin extraction to sustain operating margins near 18%. This cash cow funds corporate debt service (~¥12bn interest-bearing liabilities end-2024) and supports steady dividends even if other divisions wobble.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAir Fresheners and Deodorizers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKobayashi’s air fresheners and deodorizers are a household name in Japan, with estimated national penetration above 60% and unit margins around 25% in 2024, giving high cash returns with low production and distribution costs.\u003c\/p\u003e\n\u003cp\u003eThe domestic market is saturated and grew ~1% annually 2020–2024, so these SKUs act as Cash Cows needing maintenance-level advertising (~1–2% of sales) rather than heavy investment.\u003c\/p\u003e\n\u003cp\u003eThey generated roughly ¥10–12 billion in operating cash flow in FY2024, funding Kobayashi’s strategic projects and recovery initiatives while delivering stable profit streams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHousehold Sundries and Daily Necessities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHousehold Sundries and Daily Necessities are high-share, low-growth cash cows for Kobayashi, covering niche items like toilet cleaners and specialty laundry aids that held ~28% category share in Japan in FY2024 and generated ~¥24.5bn gross sales, funding core operations.\u003c\/p\u003e\n\u003cp\u003eThe small-market strategy lets Kobayashi dominate overlooked segments versus P\u0026amp;G\/Lion, keeping margins near 18% and producing steady free cash flow to offset recent one-off losses and ¥6.2bn compensation costs recorded in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~28% category share (FY2024)\u003c\/li\u003e\n\u003cli\u003e¥24.5bn gross sales from sundries\u003c\/li\u003e\n\u003cli\u003e~18% margin, steady free cash flow\u003c\/li\u003e\n\u003cli\u003eCovers ¥6.2bn 2024 one-off costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFever Relief Pads (Domestic Market)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eFever Relief Pads (Netsusama Sheets) dominate Japan with an estimated 38% market share in 2025 and stable annual sales near ¥22 billion, making them a classic cash cow for Kobayashi.\u003c\/p\u003e\n\u003cp\u003eHousehold penetration exceeds 60% and low promo spend (≈2% of sales) keeps margins high, funding R\u0026amp;D for next‑gen health devices and pilot consumer experiments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 sales ~¥22B\u003c\/li\u003e\n\u003cli\u003eDomestic share 38%\u003c\/li\u003e\n\u003cli\u003eHousehold penetration \u0026gt;60%\u003c\/li\u003e\n\u003cli\u003ePromo spend ≈2% of sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKobayashi’s cash cows generate ~¥45bn FCF, funding dividends, debt, R\u0026amp;D from staples\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKobayashi’s Cash Cows — OTC staples, oral care, air fresheners, sundries, and fever pads — generate steady FCF (~¥45bn 2023–25) from high shares (18–40%), low promo (1–2% sales), and margins ~18–25%, funding dividends, ¥12bn debt service and R\u0026amp;D while operating in 1% domestic growth. \u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003e2024–25 Sales\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003cth\u003ePromo\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOTC staples\u003c\/td\u003e\n\u003ctd\u003e18.3%\u003c\/td\u003e\n\u003ctd\u003e¥1.2T market\u003c\/td\u003e\n\u003ctd\u003e24%\u003c\/td\u003e\n\u003ctd\u003e1–2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOral care\u003c\/td\u003e\n\u003ctd\u003e35–40%\u003c\/td\u003e\n\u003ctd\u003e¥28.5bn\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e1–2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAir fresheners\u003c\/td\u003e\n\u003ctd\u003e60% penetration\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e25%\u003c\/td\u003e\n\u003ctd\u003e1–2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSundries\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003ctd\u003e¥24.5bn\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003ctd\u003e1–2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFever pads\u003c\/td\u003e\n\u003ctd\u003e38%\u003c\/td\u003e\n\u003ctd\u003e¥22bn\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e≈2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eKobayashi BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Kobayashi BCG Matrix document you'll receive after purchase — fully formatted, analysis-ready, and free of watermarks or demo content. This preview matches the final downloadable file, crafted for strategic clarity and immediate use in presentations, planning, or client reports. Upon purchase, the same editable document will be delivered to your inbox with no surprises or additional revisions required. Built by strategy professionals, it combines clear visuals and market-aligned insights to streamline your portfolio analysis and decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748260852089,"sku":"kobayashi-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/kobayashi-bcg-matrix.png?v=1772206682","url":"https:\/\/matrixbcg.com\/products\/kobayashi-bcg-matrix","provider":"MatrixBCG","version":"1.0","type":"link"}